Effect of melatonin intake on postural balance, functional mobility and fall risk in persons with multiple sclerosis:

Sonda Jallouli1,2, Sameh Ghroubi1,3, Imen Ben Dhia1,2

  • 1Research laboratory: Evaluation and Management of Musculoskeletal System Pathologies, LR20ES09, Faculty of Medicine, University of Sfax, Sfax, Tunisia.

Abstract

Insights

Nocturnal melatonin (MEL) ingestion improved postural balance, functional mobility, and reduced fall risk in adults with multiple sclerosis (MS) the following morning. This suggests MEL is safe and beneficial for MS patients, potentially by enhancing sleep and cognitive function.

Area of Science:

  • Neurology
  • Sleep Medicine
  • Rehabilitation Science

Background:

  • Multiple Sclerosis (MS) is a chronic neurological disease affecting balance, mobility, and fall risk.
  • Sleep disturbances are common in MS and can exacerbate neurological symptoms.
  • Melatonin (MEL) is a hormone known for its role in sleep regulation and has potential neuroprotective effects.

Purpose of the Study:

  • To evaluate the safety and efficacy of nocturnal melatonin (MEL) ingestion.
  • To assess the impact of MEL on postural balance, functional mobility, and fall risk in adults with relapsing-remitting MS (RR-MS) the next morning.

Main Methods:

  • A pilot study involving 14 adults with RR-MS.
  • Participants underwent evaluations before and after ingesting 6 mg of MEL or placebo (PLA) nocturnally.
  • Assessments included posturography, unipedal balance tests, Timed Up and Go Test (TUGT), Four Square Step Test (FSST), Timed 25-foot walk test (T25FWT), cognitive tests (MoCA, SRT), and sleep quality questionnaire (SSQ).

Main Results:

  • MEL significantly improved postural balance, indicated by reduced center of pressure (CoP) sway in eyes-open conditions compared to PLA.
  • Functional mobility and fall risk were improved with MEL, as shown by decreased TUGT and FSST durations.
  • MEL also enhanced unipedal stance time, sleep quality (SSQ), and cognitive function (MoCA) compared to placebo.

Conclusions:

  • Acute nocturnal melatonin ingestion appears safe for adults with RR-MS.
  • MEL may enhance postural balance, functional mobility, and reduce fall risk in RR-MS patients.
  • Improvements may be attributed to enhanced sleep quality and cognitive function.